Theratechnologies, sanofi-aventis sales and marketing update

Theratechnologies granted sanofi-aventis commercialization rights to Egrifta tesamorelin in Latin America, Africa and the Middle East to treat excess abdominal fat in HIV patients with lipodystrophy...